Results 291 to 300 of about 4,877,549 (387)

Perioperative Morbidity of Endometrial Cancer: A Main Research Article

, 2017
Dr Hanumant V Nipanal
openalex   +1 more source

A Scoping Systematic Review of Cannabis Use in Endometriosis

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Endometriosis, affecting 6%–10% of reproductive‐age women, causes chronic pelvic pain, dysmenorrhea, and infertility. Current treatments have limitations and consequently there is rising interest in effects of cannabis on pain and inflammation associated with endometriosis.
Kindha McLaren, Simon Erridge, Mikael H. Sodergren   +2 more
wiley   +1 more source

The role of complementary lymphadenectomy in patients with incidental endometrial cancer. [PDF]

Front Oncol
Barquet-Muñoz SA, Martínez-Alpizar P, Ramirez A, Rico-Mejía P, Pérez-Montiel D, Sepúlveda-Rivera CM, González-Ruiz J, Mohar A, Pérez-Plasencia C, Cantú-de-León D, Prada D.   +10 more
europepmc   +1 more source

Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations. [PDF]

, 2017
Cohn, David E, Goodfellow, Paul J, Kurita, Takeshi, Miranda, Mario A, Mutch, David G, O\u27Hern, Matthew J, Sapp, Caroline E, Serna, Vanida A, Walker, Christopher J   +8 more
core   +1 more source

Patient‐reported outcomes, postoperative pain and pain relief after day‐case surgery (POPPY): baseline data from day surgery practice in the UK

Anaesthesia, EarlyView.
Summary Introduction Most patients undergoing elective surgery in the UK are discharged from hospital on the same day. Despite this, there is a lack of UK patient‐centred outcome measures relating to quality of recovery, pain and analgesic use. The POPPY study was a UK‐wide prospective, observational study measuring short‐ and longer‐term patient ...
Martha Belete, Adam B. Brayne, Harriet Daykin, Matthew Everson, William M. Hare, Anna Ratcliffe, Lexy Sorrell, Mark Rockett, on behalf of the Research and Audit Federation of Trainees   +8 more
wiley   +1 more source

Dissecting endometrial cancer complexity in response to standard and targeted therapies. [PDF]

Cell Death Dis
Vaccarella S, Bruno V, Orlandi G, Covino DA, Frascolla C, Pulito C, Vizza R, Urbani G, Allegretti M, De Pascale V, Goeman F, Ciuffreda L, Arteni BAM, Di Martino S, Sacconi A, Mancini E, Bagnato A, Baiocco E, Kajal R, Vinik Y, Lev S, Fanciulli M, Vidiri A, Carosi M, Strano S, Donzelli S, Vizza E, Blandino G.   +27 more
europepmc   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

Are Uterine Manipulators Harmful in Minimally Invasive Endometrial Cancer Surgery? A Retrospective Cohort Study. [PDF]

Cancers (Basel)
Côté M, Renaud MC, Sebastianelli A, Grégoire J, Langlais ÈL, Singbo N, Plante M.   +6 more
europepmc   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Preoperative clinical predictors of lymph node metastasis in endometrial cancer: a retrospective cohort study. [PDF]

BMC Womens Health
Elkattawy AM, Almeniawy MM, Saleh MA, Haggag A, Mansor AE, Harb OA, Gertallah LM, Abdallah AM, Osman MA, Omara M.   +9 more
europepmc   +1 more source